TY - JOUR
T1 - Identification of a cellular polypeptide that distinguishes between acute lymphoblastic leukemia in infants and in older children
AU - Hanash, S. M.
AU - Kuick, R.
AU - Strahler, J.
AU - Richardson, B.
AU - Reaman, G.
AU - Stoolman, L.
AU - Hanson, C.
AU - Nichols, D.
AU - Tueche, H. J.
PY - 1989
Y1 - 1989
N2 - We analyzed the polypeptide pattern of leukemic cells of infants and older children with acute lymphoblastic leukemia (ALL), using two-dimensional polyacrylamide gel electrophoresis (PAGE). Patterns were analyzed for the occurrence of a previously detected cytosolic polypeptide, designated L3. Quantitative analysis of L3 in 12 infants and 91 older children with non-T ALL indicated lack of expression of polypeptide L3 in leukemic cells of infants which, in most cases, expressed HLA-DR and CD19 and lacked CD10. Quantitative analysis of L3 in relation to cell surface marker expression revealed that L3 was limited in its occurrence to non-T ALL and was not coordinately expressed with any of the surface markers included in the study. Among patients in the HLA-DR-positive, CD19-positive, and CD10-negative group, different levels of polypeptide L3 were observed between infants and older children. These results indicate differences in leukemic cell constituents between infants and older children with ALL and an otherwise similar cell surface marker phenotype.
AB - We analyzed the polypeptide pattern of leukemic cells of infants and older children with acute lymphoblastic leukemia (ALL), using two-dimensional polyacrylamide gel electrophoresis (PAGE). Patterns were analyzed for the occurrence of a previously detected cytosolic polypeptide, designated L3. Quantitative analysis of L3 in 12 infants and 91 older children with non-T ALL indicated lack of expression of polypeptide L3 in leukemic cells of infants which, in most cases, expressed HLA-DR and CD19 and lacked CD10. Quantitative analysis of L3 in relation to cell surface marker expression revealed that L3 was limited in its occurrence to non-T ALL and was not coordinately expressed with any of the surface markers included in the study. Among patients in the HLA-DR-positive, CD19-positive, and CD10-negative group, different levels of polypeptide L3 were observed between infants and older children. These results indicate differences in leukemic cell constituents between infants and older children with ALL and an otherwise similar cell surface marker phenotype.
UR - http://www.scopus.com/inward/record.url?scp=0024504007&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024504007&partnerID=8YFLogxK
U2 - 10.1182/blood.v73.2.527.527
DO - 10.1182/blood.v73.2.527.527
M3 - Article
C2 - 2917188
AN - SCOPUS:0024504007
SN - 0006-4971
VL - 73
SP - 527
EP - 532
JO - Blood
JF - Blood
IS - 2
ER -